|
|
Marie Migaud, PhD, Department of Pharmacology, Mitchell Cancer Institute
|
Project Seed 2023
$30,626 - Elysium Health, Inc.
(total funding, 1 year project)
|
|
|
|
Jonathan Rayner, PhD, Department of Microbiology & Immunology
|
Southeastern USA Arbovirus Landscape
$302,951 - Agricultural Research Service
(total funding, 2 year project)
|
|
|
|
Robert Allen Perkins, MD, Chair Family Practice
|
Value‐Based Medical Student Education Training Program
$16,000,000 - Health Resources and Human Services (HRSA)
(total funding, four year award)
|
|
Deadline Approaching
Intramural Grants Program
|
|
Applications must be submitted via InfoReady.
The deadline for submission is October 16th. Awards are expected to be made on December 1st.
|
|
MD with Research Honors Program Chair |
|
Seema Singh, PhD, Professor, Department of Pathology, Frederick P. Whiddon College of Medicine, Mitchell Cancer Institute, has been appointed as the new Chair of the MD with Research Honors program and committee. Dr. Singh is replacing Dr. Jonathan Scammell, who has served as chair of the Honors Committee for many years.
The M.D. with Research Honors Program is for medical students who desire to conduct biomedical research over the course of their medical school training. Many students become interested in more in-depth research opportunities after participating in the Medical Student Summer Research Program. Students who complete the program requirements will have the notation "Research With Honors" on their College of Medicine transcript and diploma.
|
|
Robert Barrington, PhD (Associate Professor, Microbiology & Immunology) has accepted the position to be the new ORET Director. Unlike the co-Directorship model that has prevailed for several years, this is now a single Directorship position. Through his teaching and his research program, Dr. Barrington has been an active contributor to the graduate program for many years. He currently serves as a block leader for IDL-581, and teaches in several other IDL courses within the Lung Biology and Infectious Disease and Host Defense graduate tracks. He also contributes to medical education and research, including serving as Chair of the Medical Student Summer Research Program and as a member of the MD with Research Honors Committee.
|
|
Number of R01 Submissions with Modular Budgets |
|
Researchers may be interested in recent trends in the College regarding submission of R01 applications with modular budgets. This follows a memo issued by the Associate Dean for Research in May 2021 encouraging investigators to submit detailed budgets rather than modular due to the declining value of a modular award relative to the true costs of conducting biomedical research. Since then, the percentage of R01 submissions with modular budgets has indeed fallen from 25% in FY21 to 11% for FY23
(year-to-date). Meanwhile, the average value of an R01 award has increased from $256,443 in FY21 (directs) to $342,620 for FY23 (year-to-date).
|
|
The most current NIH cycle has been a busy one for the College of Medicine, with the following grant applications submitted (or soon-to-be submitted):
1 P01, 1 R35, 7 R01s, and 4 R21s. In addition, there were 2 submissions for administrative supplements for ongoing R01 awards and two R01 submissions where a COM faculty member is a collaborating co-Investigator. There have also been recent submissions to other agencies, including applications to the Breast Cancer Foundation of Alabama, DOD, and the NSF. This level of activity is a testament to the hard work of our faculty and grant administrators in seeking to increase extramural support for research.
|
|
Recent Publications from COM Researchers |
|
Holloway RW, Thaker P, Mendivil AA, Ahmad S, Al-Niaimi AN, Barter J, Beck T, Chambers SK, Coleman RL, Crafton SM, Crane E, Ramez E, Ghamande S, Graybill W, Herzog T, Indermaur MD, John VS, Landrum L, Lim PC, Lucci JA, McHale M, Monk BJ, Moore KN, Morris R, O'Malley DM, Reid TJ, Richardson D, Rose PG, Scalici JM, Silasi DA, Tewari K, Wang EW. A phase III, multicenter, randomized study of olvimulogene nanivacirepvec followed by platinum-doublet chemotherapy and bevacizumab compared with platinum-doublet chemotherapy and bevacizumab in women with platinum-resistant/refractory ovarian cancer. Int J Gynecol Cancer. 2023 Sep 4;33(9):1458-1463. doi: 10.1136/ijgc-2023-004812. PMID: 37666539.
Smolen KA, Papke CM, Swingle MR, Musiyenko A, Li C, Salter EA, Camp AD, Honkanen RE, Kettenbach AN. Quantitative proteomics and phosphoproteomics of PP2A-PPP2R5D variants reveal deregulation of RPS6 phosphorylation via converging signaling cascades. J Biol Chem. 2023 Aug 10;299(9):105154. doi: 10.1016/j.jbc.2023.105154. Epub ahead of print. PMID: 37572851; PMCID: PMC10485637.
Janssens V, Wadzinski BE, Li C, Honkanen RE. Editorial: Deciphering the etiology of rare genetic disorders associated with protein phosphatases. Front Cell Dev Biol. 2023 Aug 14;11:1241606. doi: 10.3389/fcell.2023.1241606. PMID: 37645249; PMCID: PMC10461562.
Li Z, McComic S, Chen R, Kim WTH, Gaithuma AK, Mooney B, Macaluso KR, Mulenga A, Swale DR. ATP-sensitive inward rectifier potassium channels regulate secretion of pro-feeding salivary proteins in the lone star tick (Amblyomma americanum). Int J Biol Macromol. 2023 Aug 29;253(Pt 1):126545. doi: 10.1016/j.ijbiomac.2023.126545. Epub ahead of print. PMID: 37652342.
Olliff NS, Hunt MA, Paudel SS, Nguyen KN, Delcher HA, DeMeis JD, Roberts JT, Fouty BW, Audia JP, Kim JH, Borchert GM. Human YRNA 4 (HY4) plasma levels are a prognostic indicator of SARS-CoV-2 infection clinical severity. MicroPubl Biol. 2023 Aug 18;2023:10.17912/micropub.biology.000925. doi: 10.17912/micropub.biology.000925. PMID: 37662051; PMCID: MC10474479.
Kim D, Viswanathan VK, Munakomi S, Menger RP. C1 Fractures. 2023 Aug 13. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30475564.
Kim D, Davis DD, Menger RP. Spine Sagittal Balance. 2023 Aug 14. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2023 Jan–. PMID: 30521279.
|
|
|
|
|
|
|
